Metraipolis › archive › dc_8deccfeabc8f

Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study — Europe PMC PMID:41541606

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41541606
DOI: 10.1016/j.rpth.2025.103280
License (as archived): solo-consultazione
Archived: 2026-11-08T00:27:21.124Z
SHA-256 of the archived text: f20e2f0ea1d97c12aed4c084dddb955fee12d978f696d8ce82247a3f39897cb8
Stable URL of this page: https://metraipolis.com/documento/dc_8deccfeabc8f

How to cite

Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study — Europe PMC PMID:41541606 — Europe PMC (en), https://europepmc.org/article/MED/41541606 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8deccfeabc8f (Metraipolis archive dc_8deccfeabc8f, sha256 f20e2f0ea1d97c12aed4c084dddb955fee12d978f696d8ce82247a3f39897cb8)

BibTeX

@misc{dc8deccfeabc8f,
  title = {Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study — Europe PMC PMID:41541606},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41541606},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8deccfeabc8f; sha256 f20e2f0ea1d97c12aed4c084dddb955fee12d978f696d8ce82247a3f39897cb8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41541606. Agents can read the archived copy with the MCP tool read_document.